SCLEROSTINBINDENDE WIRKSTOFFE

European patent · EP3670528 · Deleted

Register entry

Publication number
EP3670528
Application number
EP19211623
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 28, 2006
Published
Jun 24, 2020
Granted
Sep 8, 2021
Deleted
Apr 28, 2026
Reason
Maximum term reached
IPC classes
C07K 14/51 (2006.01)
C07K 16/18 (2006.01)
Priority
US 677583 P 03.05.2005
US 776847 P 24.02.2006
US 782244 P 13.03.2006
US 792645 P 17.04.2006
US 411003 25.04.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 28, 2026

    Maximum term reached

    Status of protective title
    Active → Cancelled
    Cancellation date
    28.04.2026
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 28.04.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. Jan 15, 2025

    Agent removed

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern (removed)

    Published in Swissreg on 15.01.2025

  4. Jan 15, 2025

    Agent entered

    Representative
    OFFICE ERNEST FREYLINGER S.A., c/o Schluep IP Law AG, Falkenplatz 7, 3012 Bern

    Published in Swissreg on 15.01.2025

  5. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  6. May 31, 2023

    Change

    Published in Swissreg on 31.05.2023

  7. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  8. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

3 earlier entries
  1. Jun 15, 2022

    Change

    Published in Swissreg on 15.06.2022

  2. Dec 29, 2021

    Agent entered

    Representative
    OFFICE ERNEST T. FREYLINGER S.A., c/o SCHLUEP & DEGEN, P.O. BOX 8062, 3001 Bern

    Published in Swissreg on 29.12.2021

  3. Sep 8, 2021

    Granted

    Published in Swissreg on 08.09.2021

Parties

Holder

Amgen Inc.

Amgen, Inc

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Brussels, BE

Agent

OFFICE ERNEST FREYLINGER S.A.

c/o Schluep IP Law AG Falkenplatz 7, 3012 Bern

Inventor

LU, Hsieng Sen

Westlake Village, California 91362, US

GRAHAM, Kevin

Thousand Oaks, California 91362, US

HOFFMAN, Kelly Sue

Newbury Park, California 91320, US

LATHAM, John

Seattle, Washington 98119, US

PASZTY, Christopher

Ventura, California 93003, US

POPPLEWELL, Andy

Slough, Berkshire SL1 3WE, GB

SHEN, Wenyan

Thousand Oaks, California 91362, US

HENRY, Alistair James

Uxbridge, Middlesex UB8 2LX, GB

WINTERS, Aaron George

Ventura, California 93001, US

LAWSON, Alastair

Slough, Berkshire SL1 3WE, GB

WINKLER, David

Arlington, Massachusetts 02476-7326, US

ROBINSON, Martyn Kim

Slough, Berkshire SL1 3WE, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.